AAAAAA

   
Results: 1-14 |
Results: 14
Pyrimidine-2,4,6-triones: A new effective and selective class of matrix metalloproteinase inhibitors
Authors: Grams, F Brandstetter, H D'Alo, S Geppert, D Krell, HW Leinert, H Livi, V Menta, E Oliva, A Zimmermann, G
Citation: F. Grams et al., Pyrimidine-2,4,6-triones: A new effective and selective class of matrix metalloproteinase inhibitors, BIOL CHEM, 382(8), 2001, pp. 1277-1285
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts
Authors: Supino, R Polizzi, D Pavesi, R Pratesi, G Guano, F Capranico, G Palumbo, M Sissi, C Richter, S Beggiolin, G Menta, E Pezzoni, G Spinelli, S Torriani, D Carenini, N Dal Bo, L Facchinetti, F Tortereto, M Zunino, F
Citation: R. Supino et al., A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts, ONCOL-BASEL, 61(3), 2001, pp. 234-242
DNA-interactive anticancer aza-anthrapyrazoles: Biophysical and biochemical studies relevant to the mechanism of action
Authors: Sissi, C Moro, S Richter, S Gatto, B Menta, E Spinelli, S Krapcho, AP Zunino, F Palumbo, M
Citation: C. Sissi et al., DNA-interactive anticancer aza-anthrapyrazoles: Biophysical and biochemical studies relevant to the mechanism of action, MOLEC PHARM, 59(1), 2001, pp. 96-103
BBR 3464: A novel triplatinum complex, exhibiting a preclinical profile ofantitumor efficacy different from cisplatin
Authors: Manzotti, C Pratesi, G Menta, E Di Domenico, R Cavalletti, E Fiebig, HH Kelland, LR Farrell, N Polizzi, D Supino, R Pezzoni, G Zunino, F
Citation: C. Manzotti et al., BBR 3464: A novel triplatinum complex, exhibiting a preclinical profile ofantitumor efficacy different from cisplatin, CLIN CANC R, 6(7), 2000, pp. 2626-2634
Synthesis and antitumor activities of 5-methyl-1-and 2-[[2-dimethylaminoethyl]amino]-aza-thiopyranoindazoles
Authors: Krapcho, AP Haydar, SN Truong-Chiott, S Hacker, MP Menta, E Beggiolin, G
Citation: Ap. Krapcho et al., Synthesis and antitumor activities of 5-methyl-1-and 2-[[2-dimethylaminoethyl]amino]-aza-thiopyranoindazoles, BIOORG MED, 10(3), 2000, pp. 305-308
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors
Authors: Pinna, GA Curzu, MM Murineddu, G Chelucci, G Cignarella, G Menta, E Krell, HW Rastelli, G Ferrari, AM
Citation: Ga. Pinna et al., Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors, ARCH PHARM, 333(2-3), 2000, pp. 37-47
N-tert-butoxycarbonyl-N-substituted hydrazines in SNAr displacements. Synthetic pathways to N-1-substituted anthrapyrazoles, aza-anthrapyrazoles and aza-benzothiopyranoindazoles
Authors: Oliva, A Ellis, M Fiocchi, L Menta, E Krapcho, AP
Citation: A. Oliva et al., N-tert-butoxycarbonyl-N-substituted hydrazines in SNAr displacements. Synthetic pathways to N-1-substituted anthrapyrazoles, aza-anthrapyrazoles and aza-benzothiopyranoindazoles, J HETERO CH, 37(1), 2000, pp. 47-55
Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative
Authors: Lanzi, C Cassinelli, G Pensa, T Cassinis, M Gambetta, RA Borrello, MG Menta, E Pierotti, MA Zunino, F
Citation: C. Lanzi et al., Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative, INT J CANC, 85(3), 2000, pp. 384-390
Research on MMP inhibitors with unusual scaffolds
Authors: Grams, F Brandstetter, H Engh, RA Glitz, D Krell, HW Livi, V Menta, E Moroder, L Constanze, J Muller, D von Roedern, EG Zimmermann, G
Citation: F. Grams et al., Research on MMP inhibitors with unusual scaffolds, CANC DRUG, 2000, pp. 223-243
Binding of bis-substituted 2-aza-anthracenedione regioisomers to DNA: effects of the relative positioning of the side chains
Authors: Sissi, C Moro, S Zagotto, G Ellis, M Krapcho, AP Menta, E Palumbo, M
Citation: C. Sissi et al., Binding of bis-substituted 2-aza-anthracenedione regioisomers to DNA: effects of the relative positioning of the side chains, ANTI-CAN DR, 14(3), 1999, pp. 265-274
2,3-dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: Synthesis, biological evaluation, and structure-activity relationships
Authors: Antonini, I Polucci, P Kelland, LR Menta, E Pescalli, N Martelli, S
Citation: I. Antonini et al., 2,3-dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: Synthesis, biological evaluation, and structure-activity relationships, J MED CHEM, 42(14), 1999, pp. 2535-2541
Antineoplastic agents 1998
Authors: Menta, E Palumbo, M
Citation: E. Menta et M. Palumbo, Antineoplastic agents 1998, EXPERT OP T, 8(12), 1998, pp. 1627-1672
DNA-binding preferences of bisantrene analogues: Relevance to the sequencespecificity of drug-mediated topoisomerase II poisoning
Authors: Sissi, C Bolgan, L Moro, S Zagotto, G Bailly, C Menta, E Capranico, G Palumbo, M
Citation: C. Sissi et al., DNA-binding preferences of bisantrene analogues: Relevance to the sequencespecificity of drug-mediated topoisomerase II poisoning, MOLEC PHARM, 54(6), 1998, pp. 1036-1045
Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4,3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles)
Authors: Krapcho, AP Menta, E Oliva, A Di Domenico, R Fiocchi, L Maresch, ME Gallagher, CE Hacker, MP Beggiolin, G Giuliani, FC Pezzoni, G Spinelli, S
Citation: Ap. Krapcho et al., Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4,3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles), J MED CHEM, 41(27), 1998, pp. 5429-5444
Risultati: 1-14 |